平特五不中

On September 26, Heads of State will gather in New York at the United Nations (UN) General Assembly鈥檚 first-ever high-level meeting on tuberculosis (TB) to accelerate efforts to end TB and reach all affected people with prevention and care.

As a lead-up to the UN meeting, India has announced its own ambitious plans to eliminate TB by 2025. With the world鈥檚 largest TB burden and rising multidrug resistance, this will be a daunting task, particularly with private sector health care providers serving as the first point of contact for 50-70% of patients with TB symptoms in India. 鈥淭he Indian government is working hard to engage the private health sector, but little is known about the quality of care they provide,鈥� said Dr. Madhukar Pai, who is the Director of the 平特五不中 International TB Centre, a Professor of Epidemiology at 平特五不中 and a Scientist at the Research Institute of the 平特五不中 Health Centre.

According to a study published this week in PLOS Medicine, private practitioners are delivering a wide range of largely inadequate care to these patients. Dr. Pai, working with Ada Kwan, a PhD student at the University of California at Berkeley, Benjamin Daniels and Dr. Jishnu Das from the World Bank, and other colleagues, utilized 24 standardized patients (SPs) 鈥� seemingly healthy actors trained to portray four different tuberculosis case scenarios during unannounced visits 鈥� to assess management and quality outcomes of private providers stratified by qualification in Patna and Mumbai, India.

A total of 2,652 SP-provider interactions were analyzed across 473 Patna providers and 730 Mumbai providers and weighted for city-representative interpretation. Providers correctly managed SP cases according to national and international standards in only 949 interactions (35% after weighting; 95% CI 32%鈥�37%). Providers often stuck to the same erroneous protocols with other SPs, repeating their own observed actions 75% of the time in a second visit by a different patient. However, there was not a single widely adopted 鈥渃ommon practice鈥� among providers: SPs encountered a wide range of observed quality and various treatment protocols within each provider qualification stratum.

Nevertheless, there were several positive findings. First, allopathic providers with Bachelor of Medicine, Bachelor of Surgery (MBBS) degrees or higher were far more likely to correctly manage cases than non-MBBS providers (odds ratio 2.80; 95% CI 2.05鈥�3.82; p < 0.0001). Second, there was near-zero use of anti-TB drugs among non-MBBS providers. In general, these drugs were judiciously used with the correct regimen and dosage in all but five of 118 cases. Finally, providers who were presented with more diagnostic information by the patient offered better care, even if it meant referring their patients to the public sector TB program.

Kwan and Pai believe that as India seeks to eliminate TB there are clear challenges but also tremendous opportunities: 鈥淩ather than a simple message of 鈥済ood鈥� or 鈥渂ad鈥� care in the private sector, our study shows that a number of qualified physicians provide excellent care, while we also found providers who consistently mismanaged patients. Engaging quality providers, ensuring a referral chain that leads patients to these providers, and linking their patients to free TB drugs and other subsidies in the public sector could be a useful strategy for India.鈥�

The authors note that SPs cannot account for the broader mix of patients a provider sees nor can they assess how a provider might manage a patient in subsequent visits. Neither is data from the public sector available that this care can be compared to. Nevertheless, these results indicate that improving TB management among urban India鈥檚 private health sector should be a priority for India鈥檚 TB elimination strategy.

This study was funded by the Bill & Melinda Gates Foundation, Grand Challenges Canada, and the Knowledge for Change Program at the World Bank.

" by Ada Kwan, Benjamin Daniels, Vaibhav Saria, Srinath Satyanarayana, Ramnath Subbaraman, Andrew McDowell, Sofi Bergkvist, Ranendra K. Das, Veena Das, Jishnu Das and Madhukar Pai was published in PLOS Medicine.

听

听